Skip to main content
SpringerLink
Log in

HIV in Pregnancy

  • Review Article
  • Published:
Journal of Fetal Medicine

Abstract

HIV in pregnancy assumes additional importance because of the risk of perinatal transmission. With the increase in number of people living the HIV–AIDS worldwide, better ART policies and improved heath condition, more women with HIV are getting pregnant. Perinatal transmission occurs mostly during labour and delivery; transmission during antenatal period may also occur. Timely administration of appropriate ART, suppressed viral load, appropriate mode of delivery and safe feeding practices can reduce the risk of perinatal transmission to minimal. ART has evolved from single dose therapy to daily fixed-dose lifelong ART to all women irrespective of the clinical stage and CD4 count. NACO recommends tenofovir 300 mg + lamivudine 300 mg + efavirenz 600 mg once daily (TDF + 3TC + EFV) for all pregnant women to be continued lifelong after delivery. ART for the mother, safe mode of delivery, ART for newborn and exclusive breast feeding can together ensure a safe pregnancy for the mother and with minimal risk of perinatal transmission. This assumes importance in developing counties like India.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. National AIDS Control Organization, ICMR-National Institute of Medical Statistics. HIV Estimations 2017: Technical Report. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India, 2018. www.naco.gov.in/sites/default/files/India%20HIV%20Estimations%202015.pdf (accessed 3 June 2018).

  2. Working Group on Mother- to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1in Africa, America and Europe: results from 13 perinatal studies. J Acquir Immune Defic Synder Hum Retrovirol. 1995;8:506–10.

    Article  Google Scholar 

  3. Anderson JR. HIV and reproduction in A guide to the clinical care of women with HIV. Ed Anderson JR 2001; http://www.hab.hrsa.gov/.

  4. INSIGHT START Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795–807.

    Article  Google Scholar 

  5. Danel C, Moh R, Gabillard D, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;27:808–22.

    Google Scholar 

  6. WHO Data and Statistics. HIV and AIDS 2019. https://www.who.int.in/hiv/data/en. Accessed 20 May 2019.

  7. NACO Technical guidelines on Anti-Retroviral Treatment. 2018. www.naco.gov.in. Accessed 1 June 2019.

  8. Townsend CL, Byrne L, Cortina-Borja M, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011. AIDS. 2014;28:1049–57.

    Article  Google Scholar 

  9. Mandelbrot L, Tubiana R, Le Chenadec J, et al. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis. 2015;61:1715–25.

    PubMed  Google Scholar 

  10. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR. 1998;47:1–82.

  11. Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Transmission in the United States. http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. Accessed 26 May 2019.

  12. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173–80.

    Article  CAS  Google Scholar 

  13. NACO. Updated Guidelines for the Prevention of Mother to Child Transmission (PPTCT) of HIV using multi drug anti-retroviral regimen in India, 2013 [online]. www.naco.gov.in/upload/National_guidelines_for_PPTCT.pdf. Accessed June 2018.

  14. Fowler MG, Qin M, Fiscus SA, et al. Benefits and risks of antiretroviral therapy for perinatal HIV prevention. N Engl J Med. 2016;375:1726–37.

    Article  CAS  Google Scholar 

  15. Ford N, Calmy A, Mofenson L. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta analysis. AIDS. 2011;25:2301–4.

    Article  CAS  Google Scholar 

  16. Nachega JB, Uthman OA, Mofenson LM, et al. Safety of tenofovir disoproxil fumarate-based antiretroviral therapy regimens in pregnancy for HIV-infected women and their Infants: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2017;76:1–12.

    Article  CAS  Google Scholar 

  17. Watts DH. Management of human immunodeficiency virus infection in pregnancy. N Engl J Med. 2002;346:1879–91.

    Article  CAS  Google Scholar 

  18. Mitt PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Vander Hoeven L, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA. 1999;282:744–79.

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education and Research, Nehru Hospital, Chandigarh, 160012, India

    Rashmi Bagga

  2. Nova IVI Fertility, 108, Swastik Society, Navrangpura, Ahmedabad, 380009, India

    Parul Arora

Authors
  1. Rashmi Bagga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Parul Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parul Arora.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bagga, R., Arora, P. HIV in Pregnancy. J. Fetal Med. 7, 73–79 (2020). https://doi.org/10.1007/s40556-019-00224-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40556-019-00224-8

Keywords

Search

Navigation